Several recently published studies have suggested that patients who undergo ABO mismatched hematopoietic stem cell transplantation may be at increased risk for relapse, graft-versus-host disease, transplant-related mortality, and/or all-cause mortality. To investigate this issue further, we analyzed potential associations between the donor-recipient ABO mismatch pattern and the above outcome measures among 240 consecutive patients who underwent allogeneic hematopoietic stem cell transplantation at our institution. Our analyses uncovered no significant associations between donor-recipient ABO mismatch pattern and overall survival, event-free survival, transplant-related mortality, incidence of acute graft-versus-host disease (GVHD), or incidence of chronic GVHD. Our data do not support recent assertions that donor-recipient ABO mismatching is a major risk factor for patients undergoing allogeneic transplant, nor do they support recent assertions that ABO matching should be an important consideration in selecting allogeneic hematopoietic stem cell donors.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/sj.bmt.1705496 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
HLA Compatibility and Graft Survival Rates Among Related and Unrelated Donors in Renal Transplantation.
Transplant Proc
December 2024
School of Biotechnology, International University, Vietnam National University Ho Chi Minh City, Vietnam; Research Center for Infectious Diseases, International University, Vietnam National University Ho Chi Minh City, Vietnam.
Human leukocyte antigen (HLA) compatibility between donors and recipients plays a critical role in graft survival in renal transplantation. This study evaluates the impact of HLA mismatching on graft survival and rejection among renal transplant recipients with related and unrelated donors, considering factors such as age, sex, ABO blood type, and anti-HLA antibodies. We investigated the graft survival rates between related and unrelated donors in a prospective cohort study conducted from 2018 to 2020 at Cho Ray Hospital and People's Hospital 115 in Vietnam, involving 126 related and 82 unrelated donor-recipient pairs.
View Article and Find Full Text PDFEffect of Donor/Recipient ABO Mismatch on Outcome of Allogenic Hematopoietic Stem Cell Transplantation in Children: Single-center Study.
J Pediatr Hematol Oncol
January 2025
Pediatric Hematology/Oncology and Bone Marrow Transplantation Unit.
ABO blood group mismatch between donor and recipient is thought to be associated with several immunopharmacological complications but is not considered a major contraindication to allogeneic hematopoietic stem cell transplantation (HSCT). However, the impact of such a mismatch on overall survival, transplant-related mortality, graft-versus-host disease, and time to neutrophil and platelet engraftment seems to be conflicting. This retrospective cohort was carried out on children and adolescents who underwent allogenic HSCT between January 2016 and January 2023.
View Article and Find Full Text PDFMixed-field ABO front typing as an early sign of disease recurrence in ABO-matched stem cell transplantation.
Immunohematology
September 2024
1Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT.
ABO group testing is critical for allogeneic stem cell transplantation because mismatches can cause both transfusion and engraftment challenges. Even with ABO-matched donor-recipient pairs, ABO group determination may provide valuable insight into allograft status. Herein, we report a case of a 76-year-old female patient with myeloid neoplasm who underwent ABO-matched stem cell transplantation and in whom mixed-field ABO antigen expression during routine follow-up testing post-transplantation was the first sign of a change in transplant graft status; the mixed-field findings pre-dated changes in formal chimerism testing.
View Article and Find Full Text PDFRisk factors of delayed graft function following living donor kidney transplantation: A meta-analysis.
Transpl Immunol
October 2024
Department of Urology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo National Referral Hospital, Jakarta, Indonesia.
Introduction: Delayed graft function (DGF) is a common condition that necessitates dialysis during the first week after transplantation. Although DGF rarely occurs following living-donor kidney transplantation (LDKT), it may eventually lead to acute or chronic graft rejection. This study aimed to assess the risk factors for DGF in patients who underwent LDKT.
View Article and Find Full Text PDFCumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patients.
Blood Adv
September 2024
Division of Hematology/Oncology, University of Washington, Seattle, WA.
Article Synopsis
- Up to one-third of patients with blood cancers who have received multiple transfusions develop immune-mediated issues that make platelet transfusions less effective, known as platelet transfusion refractoriness.
- This study analyzed 2012 platelet transfusions in 73 patients to examine how HLA antibodies and other patient factors influence the effectiveness of these transfusions, specifically looking at their impact on the corrected count increment (CCI) after 2 and 24 hours.
- Results showed that high levels of donor-specific antibodies, certain blood type mismatches, and other specific conditions negatively affected immediate posttransfusion platelet counts, suggesting that using a computerized algorithm for donor-recipient matching could improve outcomes in these patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!